LoginSignup
GLA

GlaxoSmithKline

Stock
Stock
ISIN: PK0001301016
Ticker: GLAXO
PK0001301016
GLAXO

Price

Price

Frequently asked questions

What is GlaxoSmithKline's market capitalization?

The market capitalization of GlaxoSmithKline is $403.02M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is GlaxoSmithKline's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for GlaxoSmithKline is 24.97. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for GlaxoSmithKline?

GlaxoSmithKline's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.0507. EPS indicates the company's profitability on a per-share basis.

What is GlaxoSmithKline's revenue over the trailing twelve months?

Over the trailing twelve months, GlaxoSmithKline reported a revenue of $201.38M.

What is the EBITDA for GlaxoSmithKline?

GlaxoSmithKline's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $29.30M. EBITDA measures the company's overall financial performance.

What is the free cash flow of GlaxoSmithKline?

GlaxoSmithKline has a free cash flow of $8.75M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of GlaxoSmithKline's stock?

The 5-year beta for GlaxoSmithKline is 0.75. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does GlaxoSmithKline have, and what sector and industry does it belong to?

GlaxoSmithKline employs approximately 1,708 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of GlaxoSmithKline's shares?

The free float of GlaxoSmithKline is 45.14M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $403.02M

5Y beta

 0.75

EPS (TTM)

 0.0507

Free Float

 45.14M

P/E ratio (TTM)

 24.97

Revenue (TTM)

 $201.38M

EBITDA (TTM)

 $29.30M

Free Cashflow (TTM)

 $8.75M

Information

GlaxoSmithKline Pakistan Limited is a Pakistan-based global biopharma company. The Company is engaged in the manufacturing and marketing of research-based specialties and pharmaceutical products. It caters to therapy areas, such as anti-infectives, dermatology, respiratory, analgesics, urology, and vaccines. Its pharmaceutical brands include Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol and Ventolin. Its portfolio has three product areas: vaccines, specialty, and general medicines. Its Amoxil branded products are an antibiotic indicated for the treatment of upper respiratory tract infections and helicobacter pylori. Its Vates portfolio comprises brands, such as Dermovate, Clobevate, Cutivate, and Betnovate. Its Vates portfolio addresses to a broad category of steroid responsive dermatoses indications, contact, and other kinds of dermatitis. Its Calpol branded products are used for treatment of mild to moderate fever and pain.

1,708

Biotechnology & Drugs

Health Care

Identifier

ISIN

PK0001301016

Primary Ticker

GLAXO

Knockouts

Join the conversation
Sign upLogin